Adalimumab/infliximabAcute infusion reaction and lack of efficacy

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 1991卷 / 1期

关键词：

D O I：

10.1007/s40278-024-52528-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：16 / 16

相关论文

共 50 条

[21] Infliximab/methotrexate/tocilizumabDrug intolerance, infusion reaction and lack of efficacy: case report
Reactions Weekly, 2025, 2050 (1) : 276 - 276
[22] Multiple drugs Tuberculosis, lack of efficacy and infusion reaction : 10 case reports
Reactions Weekly, 2023, 1963 (1) : 346 - 346
[23] Multiple drugsAcute post infusion reaction and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1893 (1) : 221 - 221
[24] Adalimumab/infliximabAcute and delayed hypersensitivity reactions: case report
Reactions Weekly, 2012, 1395 (1) : 5 - 5
[25] Adalimumab/methotrexatePalmoplantar psoriasis and lack of efficacy : case report
Reactions Weekly, 2024, 2018 (1) : 22 - 22
[26] Adalimumab/etanerceptAutoimmune encephalitis and lack of efficacy: case report
Reactions Weekly, 2022, 1896 (1) : 20 - 20
[27] Adalimumab/cimetidine/infliximabAnaphylaxis and lack of efficacy: case report
Reactions Weekly, 2024, 2026 (1) : 19 - 19
[28] Adalimumab/ixekizumabTinea corporis and lack of efficacy: case report
Reactions Weekly, 2023, 1964 (1) : 18 - 18
[29] Adalimumab/infliximabPsoriasiform dermatitis and lack of efficacy: case report
Reactions Weekly, 2022, 1934 (1) : 18 - 18
[30] Adalimumab/ustekinumabAutoimmune hepatitis and lack of efficacy: case report
Reactions Weekly, 2023, 1943 (1) : 26 - 26

← 1 2 3 4 5 →